Bayer US head says tariffs will not affect its 2026 forecasts - Reuters

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxOalNWM0lpaUhsbzFBOEM4bTVqdTB3TlNXNEtwRlp0S090U0kybDNYNVJnT2JBYi02aWhYNGM5TmU0R3VTck1WZGU2c1NtWnk4eThGNlVYdHM2QWpJYXpGWC1wLVByc0hGNzZXLU1icU1qNkhHMU1BSmdxQXlfSGJrVG5nNzM1ZWc0RW1jZ1RoZ2ZyUmNPYkpJbjFXaUxCRUhKOHlRU3BB?oc=5" target="_blank">Bayer US head says tariffs will not affect its 2026 forecasts</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

Bayer Pharmaceuticals COO and U.S. President Sebastian Guth stated that the company has appropriately anticipated tariffs in its 2026 guidance, with the U.S. committed to honoring the trade deal with the European Union that caps tariffs on most goods, including medicines, at 15%.